跳至主要内容
临床试验/TCTR20180613001
TCTR20180613001已完成2 期

The clinical effect of oral vitamin D2 supplementation on psoriasis: A double-blind, randomized, placebo-controlled study

Thammasat University0 个研究点目标入组 46 人开始时间: 2018年6月13日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Patients with chronic stable plaque type psoriasis, aged 18-70 years (both men and women), mild psoriasis evaluated by using Psoriasis Area and Severity Index (PASI) score (PASI < 10), and no change of the psoriatic medication during study period

排除标准

  • Currently on systemic therapy or phototherapy or last episodes within 30 days before enrollment, hepatic impairment, renal impairment, cancer, receiving immunosuppressive medication or chemotherapy, receiving vitamin D, calcium supplement, bisphosphonate, antiepileptic agents, anticoagulants, history of hypercalcemia, nephrolithiasis, parathyroid disease, pregnancy, and breastfeeding woman

研究者

相似试验